Sartorius AG
An international partner for the biopharmaceutical industry and life science research.
SRT3 | F
Overview
Corporate Details
- ISIN(s):
- DE0007165607 (+3 more)
- LEI:
- 529900EQV2DY4FOAMU38
- Country:
- Germany
- Address:
- Weender Landstraße 94-108, 37075 Göttingen
- Website:
- https://www.sartorius.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of special-purpose machinery
Description
Sartorius is a leading international partner for the biopharmaceutical industry and life science research. The company provides a comprehensive portfolio of products and services that support the entire drug development and manufacturing process, from initial discovery to production. Key offerings include advanced solutions for filtration, fermentation, fluid management, cell analysis, and process analytics. The laboratory products division supplies essential equipment such as balances, pipettes, and water purification systems. Sartorius focuses on simplifying complex scientific processes to help customers translate discoveries into effective medicines more quickly and efficiently.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-14 00:00 |
Hinweis auf Konzernabschluss vom 01.01.2024 bis zum 31.12.2024
|
German | 5.8 KB | ||
| 2025-01-14 00:00 |
Berichtigt am 29.01.2025
|
German | 5.8 KB | ||
| 2024-12-07 18:21 |
Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sarto…
|
English | 18.9 KB | ||
| 2024-12-06 18:21 |
Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sarto…
|
English | 18.9 KB | ||
| 2024-10-21 00:00 |
Q3 statement / Q3 financial report 2024
|
English | 211.4 KB | ||
| 2024-10-07 10:35 | English | 4.0 KB | |||
| 2024-10-07 00:00 |
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2024 bis zum 30.0…
|
German | 5.8 KB | ||
| 2024-07-23 09:24 |
Sartorius AG: Dr. Lothar Ewald Kappich, buy
|
English | 9.2 KB | ||
| 2024-07-23 09:15 |
Sartorius AG: Dr. Lothar Ewald Kappich, buy
|
English | 7.9 KB | ||
| 2024-07-19 00:00 |
Half-yearly financial report 2024
|
English | 944.5 KB | ||
| 2024-07-18 21:19 | English | 4.1 KB | |||
| 2024-07-18 18:22 |
Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for…
|
English | 18.2 KB | ||
| 2024-07-18 00:00 |
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2024 bis zum 30.0…
|
German | 231.4 KB | ||
| 2024-07-18 00:00 |
Berichtigung der Veröffentlichung vom 12.07.2024
|
German | 5.8 KB | ||
| 2024-07-12 09:07 | English | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all Sartorius AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sartorius AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sartorius AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Kappich, Dr. Lothar Ewald | Supervisory board | Buy | None | 41,840.00 EUR |
| 2022-11-15 | Kreuzburg, Dr. Joachim | Board | Sell | None | 8,000,000.00 EUR |
Peer Companies
